- Learn More
The Paul, Weiss Litigation Department is led by a team of the country’s most accomplished trial lawyers. Our litigators in New York, San Francisco and Washington, D.C. handle the most complex and demanding lawsuits, class actions, government investigations, criminal prosecutions and restructurings. Our clients include Fortune 50 corporations and other prominent companies in the financial services, investment, medical device, pharmaceutical, sports, technology, energy, media and insurance industries. Every day, we are called on by chief executives, board chairs, general counsel, investors and entrepreneurs for our unmatched trial skills, sophisticated business judgment and renowned strategic advice.
Paul, Weiss Recognized by The American Lawyer for Wins in Two Major Lawsuits
- January 21, 2022
Litigation partners Bill Isaacson and Jessica Phillips, and counsel Jennifer Gordon, were all recognized by The American Lawyer’s “Litigation Daily” column for their litigation victories in two lawsuits.
On January 12, Bill and Jessica, representing Oracle alongside co-counsel at Morgan, Lewis & Bockius, secured a contempt order and sanctions against Rimini Street in a long-running copyright infringement dispute over Rimini’s software support services. The ruling, in the District of Nevada, puts Oracle in a strong position for its jury trial, which is scheduled for this fall. Also mentioned in the article were litigation associates Gabriel Schlabach, Marco Minichiello, Erica Spevack and Kirsten Dedrickson.
Jennifer won summary judgment for Genentech in patent litigation brought by Baxalta Inc. in the District of Delaware targeting Genentech’s groundbreaking hemophilia treatment HEMLIBRA®. On January 13, the court found the patent Baxalta was asserting invalid for lack of enablement—a major win in this high-stakes dispute over Genentech’s blockbuster treatment. Also mentioned in the article were litigation partners Kenneth Gallo and Catherine Nyarady, and associate Dave Cole.